![Glucagon-Receptor-Agonists-Modulators-MCE_第1頁(yè)](http://file4.renrendoc.com/view/20e7196fea9acf3d10703ea5cdf9c436/20e7196fea9acf3d10703ea5cdf9c4361.gif)
![Glucagon-Receptor-Agonists-Modulators-MCE_第2頁(yè)](http://file4.renrendoc.com/view/20e7196fea9acf3d10703ea5cdf9c436/20e7196fea9acf3d10703ea5cdf9c4362.gif)
![Glucagon-Receptor-Agonists-Modulators-MCE_第3頁(yè)](http://file4.renrendoc.com/view/20e7196fea9acf3d10703ea5cdf9c436/20e7196fea9acf3d10703ea5cdf9c4363.gif)
![Glucagon-Receptor-Agonists-Modulators-MCE_第4頁(yè)](http://file4.renrendoc.com/view/20e7196fea9acf3d10703ea5cdf9c436/20e7196fea9acf3d10703ea5cdf9c4364.gif)
![Glucagon-Receptor-Agonists-Modulators-MCE_第5頁(yè)](http://file4.renrendoc.com/view/20e7196fea9acf3d10703ea5cdf9c436/20e7196fea9acf3d10703ea5cdf9c4365.gif)
Glucagon-Receptor-Agonists-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html Glucagon HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html ReceptorGCGRGlucagon receptor is in the G protein-coupled receptor family, that is important in controlling
2、 blood glucose levels. The glucagonreceptor is a 62 kDa protein that is activated by glucagon and is a member of the class B G-protein coupled family of receptors,coupled to G alpha i, Gs and to a lesser extent G alpha q. Stimulation of the receptor results in activation of adenylate cyclase andincr
3、eased levels of intracellular cAMP. In humans, the glucagon receptor is encoded by the GCGR gene. Glucagon receptors aremainly expressed in liver and in kidney with lesser amounts found in heart, adipose tissue, spleen, thymus, adrenal glands, pancreas,cerebral cortex, and gastrointestinal tract.www
4、.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html Glucagon HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html Receptor HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedCh
5、emE/Targets/Glucagon Receptor.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html Agonists, HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html
6、 Antagonists HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html & HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html HYPERLINK https:/www.MedChemE/Targets/Glucagon Receptor.html Modulators HYPERLINK https:/www.MedChemE/
7、Adomeglivant.html Adomeglivant(LY2409021) Cat. No.: HY-19904 HYPERLINK https:/www.MedChemE/albiglutide-tfa.html Albiglutide HYPERLINK https:/www.MedChemE/albiglutide-tfa.html HYPERLINK https:/www.MedChemE/albiglutide-tfa.html TFACat. No.: HY-108795AAdomeglivant (LY2409021) is a potent, selectivegluc
8、agon receptor (GluR) allosteric antagonist.Adomeglivant is widely used in the research fortype 2 diabetes mellitus.Albiglutide TFA, a glucagon-like peptide (GLP)-1mimetic, is a long acting GLP-1 receptor agonistfor the treatment of type 2 diabetes mellitus(T2DM). Albiglutide TFA is generated by theg
9、enetic fusion of a DPP-4-resistant GLP-1 dimer tohuman albumin.Purity: 98.18%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 97.51%Clinical Data: LaunchedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Exendin_9-39.html Avexitide(Exendin (9-39) Cat. No.: HY-P0264 HYPE
10、RLINK https:/www.MedChemE/bay-55-9837.html Bay HYPERLINK https:/www.MedChemE/bay-55-9837.html HYPERLINK https:/www.MedChemE/bay-55-9837.html 55-9837Cat. No.: HY-P1160Avexitide (Exendin (9-39) is a specific andcompetitive GLP-1 receptor antagonist.Bay 55-9837 is a potent and highly selectiveagonist o
11、f VPAC2, with a K of 0.65 nM. Bayd55-9837 may be a useful therapy for the researchof type 2 diabetes.Purity: 99.70%Clinical Data: Phase 2Size: 500 g, 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/bay-55-9837-tfa.html Bay HYPERLINK https:/ww
12、w.MedChemE/bay-55-9837-tfa.html HYPERLINK https:/www.MedChemE/bay-55-9837-tfa.html 55-9837 HYPERLINK https:/www.MedChemE/bay-55-9837-tfa.html HYPERLINK https:/www.MedChemE/bay-55-9837-tfa.html TFA HYPERLINK https:/www.MedChemE/bay-55-9837-tfa.html HYPERLINK https:/www.MedChemE/BETP.html BETPCat. No.
13、: HY-P1160A Cat. No.: HY-103546Bay 55-9837 TFA is a potent and highly selectiveagonist of VPAC2, with a K of 0.65 nM. Bayd55-9837 TFA may be a useful therapy for theresearch of type 2 diabetes.BETP is an agonist of glucagon-like peptide-1(GLP-1) receptor, with EC s of 0.66 and 0.75550M for human and
14、 rat GLP-1 receptor,respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.28%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/cochinchinenin-c.html Cochinchinenin HYPERLINK https:/www.MedChemE/c
15、ochinchinenin-c.html HYPERLINK https:/www.MedChemE/cochinchinenin-c.html C HYPERLINK https:/www.MedChemE/cochinchinenin-c.html HYPERLINK https:/www.MedChemE/cotadutide-acetate.html Cotadutide HYPERLINK https:/www.MedChemE/cotadutide-acetate.html HYPERLINK https:/www.MedChemE/cotadutide-acetate.html
16、acetateCat. No.: HY-N2452(MEDI0382 acetate) Cat. No.: HY-P2231ACochinchinenin C is a nonpolypeptide agonist ofglucagon-like peptide-1 (GLP-1) receptor.Cochinchinenin C can be used for the research ofdiabetes.Cotadutide acetate (MEDI0382 acetate) is a potentpeptide dual agonist ofglucagon-like peptid
17、e-1 (GLP-1)and glucagon receptor with EC values50of 6.9 pM and 10.2 pM, respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.01%Clinical Data: Phase 2Size: 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChemE/dapiglutide.html Dapiglutide HYPERLINK https:/www.MedChemE/
18、dapiglutide.html HYPERLINK https:/www.MedChemE/ecnoglutide.html Ecnoglutide(ZP7570) Cat. No.: HY-P3291Cat. No.: HY-P3366Dapiglutide (ZP7570) is a long-acting glucagon-likepeptide-1 receptor 1R (GLP-1R)/Glucagon-likepeptide-2 receptor (GLP-2R) dual agonist.Dapiglutide can be used for short bowel synd
19、rome(SBS) research.Ecnoglutide is a glucagon-like peptide 1 (GLP-1)receptor agonist.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChe
20、mE/exendin-5-39.html Exendin HYPERLINK https:/www.MedChemE/exendin-5-39.html HYPERLINK https:/www.MedChemE/exendin-5-39.html (5-39) HYPERLINK https:/www.MedChemE/exendin-5-39.html HYPERLINK https:/www.MedChemE/KQMEEEAVRLFIEWLKNGGPSSGAPPPS.html Exendin-3/4 HYPERLINK https:/www.MedChemE/KQMEEEAVRLFIEW
21、LKNGGPSSGAPPPS.html HYPERLINK https:/www.MedChemE/KQMEEEAVRLFIEWLKNGGPSSGAPPPS.html (59-86)Cat. No.: HY-P2497 Cat. No.: HY-P1223Exendin (5-39) is a potent glucagon-like peptide 1(GLP-1) receptor antagonist. Exendin (5-39)improves memory impairment in -amyloidprotein-treated rats.Exendin-3/4 (59-86)
22、is a Exendin-4 peptidederivative.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 97.75%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/Exendin-4.html Exendin-4(Exenatide) Cat. No.: HY-13443 HYPERLINK https:/www.MedChemE/Exendin-4_A
23、cetate.html Exendin-4 HYPERLINK https:/www.MedChemE/Exendin-4_Acetate.html HYPERLINK https:/www.MedChemE/Exendin-4_Acetate.html acetate(Exenatide acetate) Cat. No.: HY-13443AExendin-4 (Exenatide), a 39 amino acid peptide, isa long-acting glucagon-like peptide-1 receptoragonist with an IC of 3.22 nM.
24、50Exendin-4 acetate (Exenatide acetate), a 39 aminoacid peptide, is a long-acting glucagon-likepeptide-1 receptor agonist with an IC of 3.2250nM.Purity: 99.98%Clinical Data: Phase 4Size: 1 mg, 5 mg, 10 mg, 25 mgPurity: 99.44%Clinical Data: Phase 4Size: 1 mg, 5 mg, 10 mg, 25 mg HYPERLINK https:/www.M
25、edChemE/FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS.html FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS HYPERLINK https:/www.MedChemE/FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS.html HYPERLINK https:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html GLP-1 HYPERLINK https:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html HYPERLINK h
26、ttps:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html moiety HYPERLINK https:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html HYPERLINK https:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html from HYPERLINK https:/www.MedChemE/GLP-1_moiety_from_Dulaglitude.html HYPERLINK https:/www.MedChemE/GLP-1_moi
27、ety_from_Dulaglitude.html DulaglutideCat. No.: HY-P1229 Cat. No.: HY-P1348FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS is anExendin-4 peptide derivative.GLP-1 moiety from Dulaglutide is a 31-amino acidfragment of Dulaglutide which is a glucagon-likepeptide 1 receptor (GLP-1) agonist, extracted frompatent US 2
28、0160369010 A1.Purity: 98.01%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 95.81%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html GLP-1 HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html HYPERLINK https:
29、/www.MedChemE/GLP-1_receptor_agonist-1.html receptor HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html agonist HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html
30、 2 HYPERLINK https:/www.MedChemE/GLP-1_receptor_agonist-1.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html GLP-1 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html receptor HYPERLINK https:/www.MedChemE/glp-1-recept
31、or-agonist-3.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html agonist HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-3.html 3Cat. No.: HY-112679 Cat. No.: HY-129656GLP-1 receptor agonist 2 is a glucagon-likepeptide-1 r
32、eceptor (GLP-1R) agonist.GLP-1 receptor agonist 3 is a GLP-1 receptoragonist extracted from patent WO2018109607A1,Example 4A-1, has EC s of 1.1 nM and 13 nM in50Clone H6 and Clone C6 cell lines assay,respectively.Purity: 99.15%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 m
33、g, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html GLP-1 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html receptor HYPERLINK https:/www.Me
34、dChemE/glp-1-receptor-agonist-4.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html agonist HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html 4 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-4.html HYPERLINK htt
35、ps:/www.MedChemE/glp-1-receptor-agonist-7.html GLP-1 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.html receptor HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.htm
36、l agonist HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-7.html 7Cat. No.: HY-129657 Cat. No.: HY-145412GLP-1 receptor agonist 4 is a glucagon-likepeptide-1 receptor (GLP-1R) agonist extractedfrom patent WO2009111700A2, compound 87, h
37、as anEC of 64.5 nM. GLP-1 receptor agonist 4 can be50used in the research for treatment of diabetes.GLP-1 receptor agonist 7 is a potent agonist ofglucagon-like peptide-1 (GLP-1). GLP-1 receptoragonist 7 has the potential for the research ofGLP-1-associated diseases, disorders, andconditions includi
38、ng diabetes mellitus (extractedfrom patent WO2021219019A1, compound 130b).Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html GLP-1 HYPERLINK https
39、:/www.MedChemE/glp-1-receptor-agonist-8.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html receptor HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html agonist HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.htm
40、l HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html 8 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-8.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html GLP-1 HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agoni
41、st-9.html receptor HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html agonist HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html HYPERLINK https:/www.MedChemE/glp-1-receptor-agonist-9.html 9Cat. No.: HY-138996 Cat. No.: HY
42、-145458GLP-1 receptor agonist 8 is a potent agonist ofGLP-1 R. GLP-1 receptor agonist 8 has thepotential for the research of diabetes, obesity,and nonalcoholic fatty liver disease (NAFLD)(extracted from patent WO2019239319A1, compound17).GLP-1 receptor agonist 9 is a GLP-1 receptoragonist, example 7
43、, extracted from WO2020234726A1.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/glp-1-28-36-amide.html GLP-1(28-36)amide HYPERLINK https:/www.MedChemE/glp-1-28-36-amide.html HYPERLINK htt
44、ps:/www.MedChemE/glp-1-28-36-amide-tfa.html GLP-1(28-36)amide HYPERLINK https:/www.MedChemE/glp-1-28-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1-28-36-amide-tfa.html TFACat. No.: HY-P3101 Cat. No.: HY-P3101AGLP-1(28-36)amide, a C-terminal nonapeptide ofGLP-1, is a major product derived fro
45、m thecleavage of GLP-1 by the neutral endopeptidase(NEP). GLP-1(28-36)amide is an antioxidant andtargets to mitochondrion, inhibits mitochondrialpermeability transition (MPT).GLP-1(28-36)amide TFA, a C-terminal nonapeptide ofGLP-1, is a major product derived from thecleavage of GLP-1 by the neutral
46、endopeptidase(NEP). GLP-1(28-36)amide TFA is an antioxidant andtargets to mitochondrion, inhibits mitochondrialpermeability transition (MPT).Purity: 96.08%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.Med
47、ChemE/glp-1-32-36-amide.html GLP-1(32-36)amide HYPERLINK https:/www.MedChemE/glp-1-32-36-amide.html HYPERLINK https:/www.MedChemE/glp-1-32-36-amide-tfa.html GLP-1(32-36)amide HYPERLINK https:/www.MedChemE/glp-1-32-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1-32-36-amide-tfa.html TFACat. No.
48、: HY-P3102 Cat. No.: HY-P3102AGLP-1(32-36)amide, a pentapeptide, derived fromthe C terminus of the glucoregulatory hormoneGLP-1. GLP-1(32-36)amide could inhibit weight gainand modulate whole body glucose metabolism indiabetic mice.GLP-1(32-36)amide TFA, a pentapeptide, derivedfrom the C terminus of
49、the glucoregulatory hormoneGLP-1. GLP-1(32-36)amide TFA could inhibit weightgain and modulate whole body glucose metabolism indiabetic mice.Purity: 98.43%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedC
50、hemE/Glucagon-Like_Peptide_GLP_I_7-36_,_amide,_human.html GLP-1(7-36), HYPERLINK https:/www.MedChemE/Glucagon-Like_Peptide_GLP_I_7-36_,_amide,_human.html HYPERLINK https:/www.MedChemE/Glucagon-Like_Peptide_GLP_I_7-36_,_amide,_human.html amide HYPERLINK https:/www.MedChemE/Glucagon-Like_Peptide_GLP_I
51、_7-36_,_amide,_human.html (Glucagon-like peptide-1 (GLP-1)(7-36), HYPERLINK https:/www.MedChemE/GLP-17-36.html GLP-1(7-36), HYPERLINK https:/www.MedChemE/GLP-17-36.html HYPERLINK https:/www.MedChemE/GLP-17-36.html amide HYPERLINK https:/www.MedChemE/GLP-17-36.html HYPERLINK https:/www.MedChemE/GLP-1
52、7-36.html acetate HYPERLINK https:/www.MedChemE/GLP-17-36.html (Glucagon-like peptide-1amide; Human GLP-1 (7-36), amide) Cat. No.: HY-P0054A (GLP-1)(7-36), amide acetate; ) Cat. No.: HY-P0054GLP-1(7-36), amide is a physiological incretinhormone that stimulates insulin secretion.GLP-1(7-36), amide ac
53、etate is a major intestinalhormone that stimulates glucose-induced insulinsecretion from cells.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.62%Clinical Data: No Development ReportedSize: 500 g, 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.html G
54、LP-1(7-36), HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.html amide HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.html TFA HYPERLINK https:/www.MedChemE/glp-1-7-36-amide-tfa.htm
55、l (Glucagon-like peptide-1 HYPERLINK https:/www.MedChemE/GLP-17-37.html GLP-1(7-37)(GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA) Cat. No.: HY-P0054BCat. No.: HY-P0055GLP-1(7-36), amide TFA is a major intestinalhormone that stimulates glucose-induced insulinsecretion from cells.GLP-1(7-37)
56、 is an intestinal insulinotropichormone that augments glucose induced insulinsecretion.Purity: 99.20%Clinical Data: No Development ReportedSize: 500 g, 1 mg, 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMe
57、dChemE HYPERLINK https:/www.MedChemE/GLP-1_7-37_acetate.html GLP-1(7-37) HYPERLINK https:/www.MedChemE/GLP-1_7-37_acetate.html HYPERLINK https:/www.MedChemE/GLP-1_7-37_acetate.html acetate HYPERLINK https:/www.MedChemE/GLP-1_7-37_acetate.html HYPERLINK https:/www.MedChemE/glp-1-9-36-amide.html GLP-1
58、(9-36)amideCat. No.: HY-P0055A Cat. No.: HY-P1141GLP-1(7-37) acetate is an intestinalinsulinotropic hormone that augments glucoseinduced insulin secretion.GLP-1(9-36)amide is a major metabolite ofglucagon-like peptide-1-(7-36) amide formed by theenzyme dipeptidyl peptidase-4 (DPP-4).GLP-1(9-36)amide
59、 acts as an antagonist to thehuman pancreatic GLP-1 receptor.Purity: 99.33%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mgPurity: 99.20%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/glp-1-9-36-amide-tfa.html GLP-1(9-36)amide HYPERLINK https
60、:/www.MedChemE/glp-1-9-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1-9-36-amide-tfa.html TFA HYPERLINK https:/www.MedChemE/glp-1-9-36-amide-tfa.html HYPERLINK https:/www.MedChemE/glp-1r-agonist-1.html GLP-1R HYPERLINK https:/www.MedChemE/glp-1r-agonist-1.html HYPERLINK https:/www.MedChemE/gl
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度物流園區(qū)倉(cāng)儲(chǔ)管理合同范本二零二五
- 2025年度戶外拓展活動(dòng)安全防護(hù)用品供應(yīng)合同
- 2025年度新能源汽車關(guān)鍵零部件模具設(shè)計(jì)與制造合同范本
- 臨沂沂州醫(yī)院2025年醫(yī)護(hù)人員培訓(xùn)項(xiàng)目合同
- 2025年敬老院土地租賃與養(yǎng)老機(jī)構(gòu)智能化改造合同
- 2025年商用空調(diào)系統(tǒng)安裝與售后服務(wù)合同
- 2025年度婚慶婚禮現(xiàn)場(chǎng)婚車租賃與裝飾合同
- 2025年度高端商務(wù)車租賃服務(wù)合同
- 2025年度寵物用品研發(fā)與創(chuàng)新合作合同
- 2025年度跨境電商進(jìn)口商品質(zhì)量安全監(jiān)管合同
- 拉擠樹脂及其成型工藝介紹課件
- 軸套類零件件的加工課件
- 北京市水務(wù)安全生產(chǎn)風(fēng)險(xiǎn)評(píng)估指南
- 吸引器教學(xué)講解課件
- 醫(yī)學(xué)心理學(xué)人衛(wèi)八版66張課件
- 物業(yè)服務(wù)五級(jí)三類收費(fèi)重點(diǎn)標(biāo)準(zhǔn)
- 工商注冊(cè)登記信息表
- 仿古建筑施工常見質(zhì)量通病及防治措施
- 漢代儒學(xué)大師董仲舒思想課件
- 普通沖床設(shè)備日常點(diǎn)檢標(biāo)準(zhǔn)作業(yè)指導(dǎo)書
- 科技文獻(xiàn)檢索與利用PPT通用課件
評(píng)論
0/150
提交評(píng)論